It has been employed as monotherapy or combined with chemotherapy in cancer (NCT02676869) [45], in metastatic BC (NCT00349934), in patients with melanoma (NCT01308294) and with PD-1 in SCCHN (NCT03625323). Here, PDCD1 is linked to breast cancer.